View all news

ResMed Presents Global Prevalence of Mild Obstructive Sleep Apnea among Women, PAP’s Cost-Saving Abilities, at SLEEP 2023


Conference: SLEEP 2023
Who attends: ~4,000 physicians, researchers, and solutions providers for all things sleep from across the U.S. and around the world.
When: June 3–7, 2023
Where: Indiana Convention Center | 100 S Capitol Ave, Indianapolis, IN 46225

Key research presentations
ResMed continues to advance the world’s knowledge of both the prevalence of sleep apnea and the cost-saving benefits of treating it with positive airway pressure (PAP):

  • Global Prevalence of Mild Obstructive Sleep Apnea in Females
    • Monday, June 5, 12–1:15 p.m., Poster Hall
    • Presented by: Alison Wimms, PhD
  • Positive Airway Pressure for Obstructive Sleep Apnea in Diastolic and Systolic Heart Failure Patients Reduces Healthcare Resource Utilization
    • Monday, June 5, 5–6 p.m., Poster Hall 
    • Presented by: Fatima Sert Kuniyoshi, MSc, PhD

ResMed supported a total 10 abstracts being presented at SLEEP.

ResMed Booth #503
Stop by Booth #503 throughout the show to see ResMed’s latest digital solutions for diagnosing and treating sleep apnea, a chronic condition that affects over 54 million Americans and 936 million people worldwide (Lancet Respir Med 2019).

People with sleep apnea are up to 87% adherent on positive airway pressure (PAP) treatment when both remotely and self-monitored (CHEST 2018).

Media questions/requests:
Contact Kristin Deuber, +1 614.975.4186,  

# # #

Multimedia Files:

View all news